Vimarsana
Biggest News Aggregation in the World

Page 37 - Biotechnology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biotechnology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biotechnology Today - Breaking & Trending Today

Toxicology Testing Market size is set to grow by USD 32.58 billion from 2024-2028, High regulatory compliance in food industry boost the market, Technavio - Vimarsana News

Toxicology Testing Market size is set to grow by USD 32.58 billion from 2024-2028, High regulatory compliance in food industry boost the market, Technavio

/PRNewswire/ -- The global toxicology testing market size is estimated to grow by USD 32.58 billion from 2024-2028, according to Technavio. The market is...

Children's Tumor Foundation invests in Healx to advance Neurofibromatosis Type 1 treatments - Vimarsana News

Children's Tumor Foundation invests in Healx to advance Neurofibromatosis Type 1 treatments

/PRNewswire/ -- Healx, the AI-powered, patient-inspired, techbio company pioneering the next generation of drug discovery, today announced that it has signed...

Dr. Paul Savage Unveils Pioneering Plasma Exchange Protocol: Reverses Toxins & Inflammation - Vimarsana News

Dr. Paul Savage Unveils Pioneering Plasma Exchange Protocol: Reverses Toxins & Inflammation

/PRNewswire/ -- New research indicates plasma exchange therapy reverses toxins and increases lifespan. In a landmark presentation at the 2024 Age Management...

ACMG Foundation for Genetic and Genomic Medicine Elects Four Highly Accomplished Medical Genetics Professionals to its Board of Directors - Vimarsana News

ACMG Foundation for Genetic and Genomic Medicine Elects Four Highly Accomplished Medical Genetics Professionals to its Board of Directors

/PRNewswire/ -- The ACMG Foundation for Genetic and Genomic Medicine (ACMGF) announced today that Marilyn C. Jones, MD, FACMG; Harry Ostrer, MD, FACMG; Lisa G....

Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance - Vimarsana News

Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance

/PRNewswire/ -- Invitae (OTC: NVTA), a leading medical genetics company, today announced new studies to be presented at the American Society of Breast Surgeons...